Investment
Features
FeesSafety
Academy
More
Pluang+

Compare United States Natural Gas Fund (UNG) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

United States Natural Gas FundTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

United States Natural Gas Fund vs Zimmer Biomet Holdings Inc — how do they compare? United States Natural Gas Fund trades at $10.05, while Zimmer Biomet Holdings Inc trades at $94.73 (market cap $18.05B). The key difference: Zimmer Biomet Holdings Inc pays a 1.01% dividend while United States Natural Gas Fund pays none, and Zimmer Biomet Holdings Inc is trading nearer its 52-week high, United States Natural Gas Fund nearer its low. Which is the better fit depends on your goals.

UNGZBH
Sector
Commodities - EnergyHealth
52-Week High
$16.90$104.26
52-Week Low
$9.63$79.58
Market Cap
$18.05B
Enterprise Value
$25.11B
Dividend Yield
1.01%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

United States Natural Gas Fund

UNG trades at $10.46, down 0.95% with a bearish technical signal from moving averages. The ETF faces headwinds from high natural gas production and storage levels, though weather-driven demand provides some support. Recent EIA forecasts project record natural gas supply and demand through 2027, creating a mixed fundamental backdrop for this futures-based commodity ETF.

The outlook remains challenged by oversupply concerns, though long-term demand growth from LNG exports and data center power needs offers potential upside. Key risks include commodity price volatility and the structural limitations of futures-based ETFs versus equity-based alternatives like FCG.

Zimmer Biomet Holdings Inc

ZBH trades at $94.22, down 3.93% on the day, with a bearish technical signal but oversold RSI readings. Recent earnings beats and raised 2026 guidance support fundamentals, with revenue growth and strong gross margins. Leadership promotions aim to accelerate commercial transformation, while cash flow trends show operational strength.

The stock offers upside to the $104.88 consensus target, but faces headwinds from debt levels and competitive pressures. Near-term support at $92 is critical; a hold rating aligns with mixed analyst views. Earnings execution and procedure demand growth are key catalysts for valuation expansion.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About United States Natural Gas Fund

UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.

Read more on UNG

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH